MedPath

深圳市中联制药有限公司

Ownership
-
Established
1988-10-11
Employees
-
Market Cap
-
Website
http://www.zlzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

NMPA:59

Drug Approvals

Levothyroxine Sodium

Product Name
左甲状腺素钠
Approval Number
国药准字H20000285
Approval Date
Dec 27, 2024
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H44024929
Approval Date
Apr 15, 2021
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H44025301
Approval Date
Apr 15, 2021
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H44021800
Approval Date
Apr 15, 2021
NMPA

Calcium Folinate Tablets

Product Name
弗利能
Approval Number
国药准字H20000517
Approval Date
Apr 15, 2021
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H44023409
Approval Date
Apr 15, 2021
NMPA

消炎利胆片

Approval Number
国药准字Z44021102
Approval Date
Apr 15, 2021
NMPA

Pancreatic Kininogenase Enteric-coated Tablets

Product Name
胰激肽原酶肠溶片
Approval Number
国药准字H20059366
Approval Date
Jan 25, 2021
NMPA

Metformin Hydrochloride Sustained-release Tablets

Product Name
众氏得
Approval Number
国药准字H20041221
Approval Date
Jan 5, 2021
NMPA

Chloroquine Phosphate Tablets

Product Name
磷酸氯喹片
Approval Number
国药准字H44021798
Approval Date
Jan 5, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.